BATTLESCARRED: NT-proBNP-guided Therapy Improves Mortality in Older Patients with Chronic HF

Cardiology Today -- The implementation of a hormone-guided treatment strategy guided by N-terminal pro-B-type natriuretic peptide levels selectively improved longer-term mortality in patients 75 years and older with chronic HF.